Project SOLO CONTINUE – R668-AD-1415
Basic data
Acronym:
SOLO CONTINUE
Title:
R668-AD-1415
Duration:
01/08/2015 to 31/01/2016
Abstract / short description:
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY INVESTIGATING THE EFFICACY AND SAFETY OF MULTIPLE DUPILUMAB DOSE REGIMENS ADMINISTERED AS MONOTHERAPY FOR MAINTAINING TREATMENT RESPONSE IN PATIENTS WITH ATOPIC DERMATITIS
Keywords:
skin diseases
Hautkrankheiten
antibodies
Antikörper
Involved staff
Managers
Faculty of Medicine
University of Tübingen
University of Tübingen
Department of Dermatology
Hospitals and clinical institutes, Faculty of Medicine
Hospitals and clinical institutes, Faculty of Medicine
Local organizational units
Department of Dermatology
Hospitals and clinical institutes
Faculty of Medicine
Faculty of Medicine
Funders
Tarrytown, New York, United States of America